Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations
Benzinga
AUGUST 12, 2024
Additionally, the combined company expects mid-teens year-over-year revenue growth in fiscal years 2025 and 2026. Through optimizing marketing spend and back office functions, the combined company expects to realize at least $15 million of annualized cost savings, most of which will be realized in fiscal year 2025.
Let's personalize your content